about
Review of Toxic Epidermal NecrolysisInflammation in Chronic WoundsPrognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinomaPreeclamptic decidual microvascular endothelial cells express lower levels of matrix metalloproteinase-1 than normals.Intercellular adhesion molecule-1 (ICAM-1) expression is necessary for monocyte adhesion to the placental bed endothelium and is increased in type 1 diabetic human pregnancy.Monocyte adhesion to decidual endothelial cells is increased in pregnancies complicated by type 1 diabetes but not by gestational diabetes.In vitro migration of cytotrophoblasts through a decidual endothelial cell monolayer: the role of matrix metalloproteinases.Interaction of cocultured decidual endothelial cells and cytotrophoblasts in preeclampsia.Leukocyte matrix metalloproteinase-9 is elevated and contributes to lymphocyte activation in type I diabetes.Anti-IgD antibody attenuates collagen-induced arthritis by selectively depleting mature B-cells and promoting immune tolerance.Activated protein C inhibits proliferation and tumor necrosis factor α-stimulated activation of p38, c-Jun NH2-terminal kinase (JNK) and Akt in rheumatoid synovial fibroblastsActivated protein C inhibits pancreatic islet inflammation, stimulates T regulatory cells, and prevents diabetes in non-obese diabetic (NOD) mice.Low circulating protein C levels are associated with lower leg ulcers in patients with diabetesActivated protein C differentially regulates both viability and differentiation of osteoblasts mediated by bisphosphonatesMyocardial extracellular matrix remodeling in ischemic heart failure.Endothelial protein C receptor-associated invasiveness of rheumatoid synovial fibroblasts is likely driven by group V secretory phospholipase A2.Toxic epidermal necrolysis: review of pathogenesis and management.Activated protein C and its potential applications in prevention of islet β-cell damage and diabetes.Sphingosine-1-phosphate protects against bisphosphonate‑induced HUVEC cell death via regulation of c-Jun‑N‑terminal kinase signaling.SIRT1, a class III histone deacetylase, regulates TNF-α-induced inflammation in human chondrocytes.Novel Functions of the Anticoagulant Activated Protein C in Maintaining Skin Barrier Integrity to Impact on Skin Disease.The Endothelial Protein C Receptor Is a Potential Stem Cell Marker for Epidermal Keratinocytes.The differential expression of protease activated receptors contributes to functional differences between dark and fair keratinocytes.Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.Differential effects of photofrin, 5-aminolevulinic acid and calphostin C on glioma cells.Isolation and propagation of endothelial cells derived from rheumatoid synovial microvasculature.Constitutive secretion of MMP9 by early-passage cultured human endothelial cells.Sulfated polysaccharides are required for collagen-induced vascular tube formation.Type I collagen fibrils promote rapid vascular tube formation upon contact with the apical side of cultured endothelium.Activated protein C stimulates proliferation, migration and wound closure, inhibits apoptosis and upregulates MMP-2 activity in cultured human keratinocytes.Activated protein C (APC) can increase bone anabolism via a protease-activated receptor (PAR)1/2 dependent mechanism.Treatment of chronic leg ulcers with topical activated protein C.Activated protein C prevents inflammation yet stimulates angiogenesis to promote cutaneous wound healing.Activated protein C binds directly to Tie2: possible beneficial effects on endothelial barrier function.Effect of activated protein C in second intention healing of equine distal limb wounds: a preliminary study.Microenvironment and macroenvironment in hypertensive hearts: boundaries and silos--can we pick and treat diastolic heart failure?Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation.Activated protein C utilizes the angiopoietin/Tie2 axis to promote endothelial barrier function.Characterisation of the macroporosity of polycaprolactone-based biocomposites and release kinetics for drug delivery.Aberrant levels of natural IgM antibodies in osteoarthritis and rheumatoid arthritis patients in comparison to healthy controls.
P50
Q28074097-B3AC01D1-249F-4992-810F-3135E3B902EBQ28075962-ACB28CCC-1994-4D9C-A285-6B4048E0F124Q28274499-CAE38B6F-B61C-4C26-B7A1-801BE5203275Q30700181-FF552465-E59F-43C3-85FE-7977E9A860B2Q30835616-37EA5A90-E419-4BBB-9FDA-6EEB2AA899D7Q31116799-B5B49465-6677-45F4-849A-73F43A5534BBQ33186520-2E4CCC96-2458-422F-A562-020EEB88ABC6Q33199751-04661857-A244-451D-80BE-17713A3D05A9Q33220680-DF7BD733-82FC-4706-8E59-F7355235DADAQ33574154-89C7AA9D-BC89-46AA-A97C-7FC78E80D286Q35130879-51A1B1B2-091F-4444-9D97-321A87F0A2ADQ35956613-65C74140-01ED-474A-85BA-B655F55E7E80Q36635469-E8A8A4A0-E68C-4DD2-9BF8-06F0DABE7E0AQ36645839-7F4B8CBF-B406-4184-92DD-4490AFF886FDQ36664601-36EE19E8-F1DD-442F-AC86-F238633F9444Q37691187-2F84ED04-2CDA-4954-8636-768891E4AE3FQ37968407-D6FC2EF0-21F8-4A5B-BEA7-80244AF61939Q38190202-230ECC65-D514-42D8-9FE2-710BC4FA4BCAQ38453571-879340DE-09F2-4FDA-B81B-0B29077FE10AQ38455313-6F8406F6-6E0A-4ACA-872F-4BC5A49F6BE7Q38544669-6A26708C-D010-47EE-8A13-CA2D32842348Q38798963-2850CC2D-BC38-4D63-AA3A-B56C369B6B00Q39097502-C0D785F7-F171-4224-952D-979AB22CA3ADQ39852991-E2AC01D0-D347-4FF9-ABCA-DBD392D7C963Q40257254-01B54E3C-7296-410B-8542-DC31E2855EA9Q41211507-DB311112-8AFD-4F44-A8C6-9D48562A0F10Q42452992-DE56D11B-3425-4EC8-A449-319CA381A2CBQ42476726-D1D1B0A2-538E-494D-893E-64BF3ACA39D9Q43475632-701451AD-6315-47F9-95E9-966571509922Q45012436-44B2D43D-2FCE-4593-AD3E-9AF0038A5E71Q45073367-EEDC7E4E-50A8-4FEC-A0F9-44FB4B067854Q46241279-F1DAC70C-ACA0-4FCB-BDB9-DB4E49CBA706Q46543534-4DB42B1F-B308-48AE-B072-B59C8ADAFD6EQ48125007-58151FA9-4D18-4091-AA93-0B135B77D296Q48127917-040AB073-EB18-43CD-9431-72AFF8797147Q48231336-D4C1166A-8C14-4543-B8AF-2B4BEB1AFA0AQ50426482-AA33488F-65EC-4F19-A3DD-EFA48156319AQ50449753-AE150C66-0B0D-4B63-B101-3A962D966D5AQ50949341-060D9A07-A589-4976-9D7D-EAD185D9C2F3Q53219863-DF191E95-92BA-44DB-B891-8EFCFA57C1DF
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Christopher J Jackson
@ast
Christopher J Jackson
@en
Christopher J Jackson
@es
Christopher J Jackson
@nl
type
label
Christopher J Jackson
@ast
Christopher J Jackson
@en
Christopher J Jackson
@es
Christopher J Jackson
@nl
prefLabel
Christopher J Jackson
@ast
Christopher J Jackson
@en
Christopher J Jackson
@es
Christopher J Jackson
@nl
P106
P1153
27170432600
P21
P31
P496
0000-0002-9234-9116